ArticlemedRxiv : the preprint server for health sciences2025
Evaluation of Amyloid Removal as a Surrogate for Cognitive Decline: Pilot Analysis in Individual-Level Data from the A4 Study of Solanezumab.
Sarah F Ackley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.